HPV Vaccine: The Cancer-Prevention Shot for Preteens
HPV is a virus so common that nearly every sexually active adult catches it at some point, usually without knowing. Some strains cause cancer — about 36,000 cases a year in the US, in women and men. The vaccine prevents the infections that cause most of them. Think of it the way you think of hepatitis B's vaccine: a cancer vaccine, given years before exposure, because that's when it works.
Key takeaways
- HPV causes nearly all cervical cancers plus many throat, anal, penile, vaginal, and vulvar cancers.
- The vaccine prevents ~90% of HPV-caused cancers when given before exposure.
- Best at ages 9–12, when the immune response is strongest — only 2 doses if started before 15.
- Countries that vaccinated early (Australia) are on track to eliminate cervical cancer as a public-health problem.
When it's given:
The disease, in plain words
Human papillomavirus spreads through intimate skin-to-skin contact. Most infections vanish silently. But when the high-risk strains persist, they can slowly — over 10 to 20 years — turn normal cells into cancer. For decades, cervical cancer was a leading cancer killer of women; the Pap smear gave us early detection. HPV vaccination gives us something better: prevention. The strains in the vaccine cause about 90% of cervical cancers and the majority of HPV cancers in men, including the fast-rising throat cancers.
The critical fact: the vaccine prevents infection; it cannot treat it. It only works if given before exposure. That's not a statement about your child's behavior — it's biology and timing, the same reason we give hepatitis B vaccine in infancy rather than waiting for a teenager to be at risk.
What the vaccine does
The vaccine contains empty shells of the virus's outer protein — no viral DNA, nothing that can infect or cause cancer. It produces antibody levels many times higher than natural infection does. Since the first version in 2006, over 135 million doses have been given in the US with close monitoring; the common side effects are a sore arm and, in teens, fainting after shots (a needle response, not a vaccine ingredient — we have them sit for 15 minutes).
When it's given
- Ages 9–12: 2 doses, 6–12 months apart (the AAP endorses starting at 9)
- Starting at 15+: 3 doses
- Catch-up: recommended through age 26 for anyone not yet vaccinated
What to expect afterward
A sore arm for a day or two is typical. Teenagers sometimes faint with any shot, so offices observe them seated for 15 minutes. Serious allergic reactions are extremely rare.
Questions parents ask me
My child isn't sexually active. Why now?
For the same reason we don't wait for a house fire to buy insurance: the vaccine must precede exposure, exposure is nearly universal in adulthood, and the immune response at 9–12 is the strongest it will ever be — which is why younger kids need 2 doses while older teens need 3. Waiting only weakens the protection.
Doesn't vaccinating encourage riskier behavior?
This has been studied directly, many times: vaccinated teens do not start sexual activity earlier or take more risks than unvaccinated teens. Seatbelts don't cause speeding, and this vaccine doesn't change behavior — it prevents cancer.
Is it only for girls?
No. Boys get HPV cancers too — throat cancer from HPV now outnumbers cervical cancer in the US. Vaccinating boys prevents those cancers and reduces transmission. The recommendation is for all children.
Keep exploring: Tdap: the other preteen shot · Meningitis vaccines · The full vaccine guide
Get clear guidance in the moment you need it
ER4Kids puts weight-based dosing, symptom guidance, and step-by-step emergency instructions in your pocket — created by a pediatric emergency medicine physician.